Plerixafor

Specifications

110078-46-1CAS Number

842-163-8EC Number

1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecaneIUPAC Name

C28H54N8Chemical Formula

502.8 g/molMolecular Weight

Plerixafor; 110078-46-1; Mozobil; AMD3100; Amd 3100; SDZ SID 791; plerixaforum; 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane; JKL 169; JM3100; S915P5499N; CHEBI:125354; DTXSID70869520; 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane; 1,4,8,11-Tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-; 1,1'-(1,4-PHENYLENEBIS(METHYLENE))BIS-1,4,8,11-TETRAAZACYCLOTETRADECANE; 1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane; mezobil; RPA bicyclam; 1-((4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl)methyl)-1,4,8,11-tetraazacyclotetradecane; 1-((4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl)methyl)-1,4,8,11-tetrazacyclotetradecane; RefChem:57592; DTXCID60817494; L03AX16; 1,1'-(1,4-Phenylenebis(methylene))-bis-1,4,8,11-tetraazacyclotetradecane; 1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane; 1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane)octahydrochloride dihydrate; 842-163-8; 1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene; bicyclam JM-2987; Plerixafor hydrochloride; AMD-3100; MFCD05662218; Plerixafor 8HCl; CHEMBL18442; C28H54N8; 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane]; plerixafor (amd3100); 1,1'-[1,4-phenylenebis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane); Mozobil (TN); Plerixafor [USAN]; Plerixafor [USAN:INN:BAN]; SID791; UNII-S915P5499N; GNA & AMD-3100; HHA & AMD-3100; VH6; JM 2987; Plerixafor (Standard); PLERIXAFOR [MI]; PLERIXAFOR [INN]; PLERIXAFOR [JAN]; PLERIXAFOR [VANDF]; PLERIXAFOR [MART.]; Plerixafor (AMD3100)?; PLERIXAFOR [WHO-DD]; SCHEMBL19038; GTPL844; Plerixafor (JAN/USAN/INN); PLERIXAFOR [EMA EPAR]; orb1307465; PLERIXAFOR [ORANGE BOOK]; AMD-3100 (CXCR4); YIQPUIGJQJDJOS-UHFFFAOYSA-N; GLXC-06682; EX-A1762; WZB81987; BDBM50035696; EBC-13587; HY-10046R; NSC754363; NSC761388; s8030; 1,1'-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}; AKOS005266706; CCG-269710; CS-0451; DB06809; FP36846; NSC-754363; NSC-761388; NCGC00165722-01; NCGC00165722-02; NCGC00165722-03; NCGC00165722-17; 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Galanthus nivalis agglutinin (GNA); 1-({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)-1,4,8,11-tetraazacyclotetradecane; AC-26837; AS-42504; HY-10046; SY042073; NS00004748; P2678; D08971; EN300-187119; AB01566900_01; F362020; L000104; Q905835; SR-01000941593; SR-01000941593-1; 11''''-xylyl bis-1,4,8,11-tetraazacyclotetradecane; BRD-K33240821-001-03-9; BRD-K33240821-001-05-4; BRD-K33240821-001-06-2; BRD-K33240821-367-01-8; BRD-K33240821-400-02-5; Z1889837352; 1,1''''-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}; 1,1'-(benzene-1,4-diyldimethanediyl)bis(1,4,8,11-tetraazacyclotetradecane); 1,1'[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane; 1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin( HHA); 1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane; 1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane(8HBr.2H2O); 11-{4-[4,8, 11-1,4,8,11tetraaza-cyclotetradec-1-ylmethyl]-benzyl}-1,4,8,11tetraaza-cyclotetradecane-1,4,8-tricarboxylic acid tri-tert-butyl esterSynonyms